Literature DB >> 6027382

Agranulocytosis coincident with amodiaquine therapy.

K Booth, K Larkin, I Maddocks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6027382      PMCID： PMC1845193          DOI： 10.1136/bmj.3.5556.32

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Fatal agranulocytosis during treatment with a amodiaquine.

Authors:  L GLICK
Journal:  Br Med J       Date:  1957-04-20

2.  Nearly fatal reaction to amodiaquine.

Authors:  H O PERRY; L G BARTHOLOMEW; D G HANLON
Journal:  JAMA       Date:  1962-02-24       Impact factor: 56.272

3.  Evaluation of amodiaquin (camoquin) in the treatment of relapsing vivax malaria.

Authors:  J LOVE; R FOULK; R G W WILLIAMS; R B MITCHELL
Journal:  Am J Med Sci       Date:  1953-01       Impact factor: 2.378
  3 in total
  4 in total

1.  An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII.

Authors:  Paul S Donnelly; Jeffrey R Liddell; SinChun Lim; Brett M Paterson; Michael A Cater; Maria S Savva; Alexandra I Mot; Janine L James; Ian A Trounce; Anthony R White; Peter J Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

2.  Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro.

Authors:  D E Lind; J A Levi; P C Vincent
Journal:  Br Med J       Date:  1973-02-24

3.  The disposition of amodiaquine in man after oral administration.

Authors:  P Winstanley; G Edwards; M Orme; A Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

4.  The disposition of amodiaquine in Zambians and Nigerians with malaria.

Authors:  P A Winstanley; O Simooya; J M Kofi-Ekue; O Walker; L A Salako; G Edwards; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.